FIELD: chemistry.
SUBSTANCE: invention relates to new compounds of the formula (1a) or its pharmaceutically acceptable salt, esters or imides where A is a thiophenyl group containing, probably, substitution, the thiophenyl group A containing, probably, substitution with one or several groups as follows: alkyl, halo or arylalkyl, Y is O, S or NR2 where R2 is hydrogen or alkyl group containing 1 to 6 carbon atoms, and R1 is an non-ramified alkyl group containing 6 to 25 carbon atoms, ramified alkyl group containing 6 to 25 carbon atoms, aryl alkyl group where the alkyl group contains 2 to 25 carbon atoms or phenyl group containing substitution with one or several groups as follows: phenyloxy, phenylthio, SO2-phenyl, alkylphenyl, CO-phenyl, CONR16- phenyl, NR16CO-phenyl or NR16 -phenyl containing, probably, substitution where R16 is hydrogen or alkyl group containing 1 to 4 carbon atoms, the groups phenyloxy, phenylthio, SO2-phenyl, alkylphenyl, CO-phenyl, CONR-phenyl or NR-phenyl containing, probably, substitution with one or several groups as follows: halo, alkyl, alkylhalo or phenyl group containing substitution with one or several groups or alkyl groups provided the above compound is not 5-methyl-2-(4-metoxyphenyl)amino-4H-thieno[2,3-d][1,3]oxazine-4-on, 6-amyl-2-(4-chlorophenyl)amino-4H-thieno[2,3-d][1,3]oxazine-4-on or 6-amyl-2-(4-metoxyphenyl)amino-4H-thieno[2,3-d][1,3]oxazine-4-on Invention also relates to method of obtaining compounds of the formula (Ia) or (IIa), to pharmaceutical compound and application, as well as cosmetic technique.
EFFECT: obtaining of new biologically active compounds and pharmaceutical compounds based on them.
27 cl, 4 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 2-AMINO-4H-3,1-BENZOXAZINE-4-ONE FOR PROPHYLAXIS OR TREATMENT OF OBESITY OR ACCOMPANYING DISORDER | 2000 |
|
RU2244711C2 |
DERIVATIVES OF 2-OXY-4H-3,1-BENZOXAZINE-2-ONE FOR PROPHYLAXIS AND/OR TREATMENT OF OBESITY OR ACCOMPANYING DISORDER | 2000 |
|
RU2245331C2 |
Axl INHIBITORS APPLICABLE IN COMBINATION THERAPY FOR PREVENTING, RELIEVING OR TREATING METASTATIC CANCER | 2010 |
|
RU2555326C2 |
SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITION ACTIVITY | 2000 |
|
RU2260008C2 |
THIENOPYRROL DERIVATIVES FOR APPLICATION FOR TARGETING PROTEINS, COMPOSITIONS WITH SAID DERIVATIVES, METHODS AND APPLICATIONS | 2017 |
|
RU2771166C2 |
GLUCOKINASE ACTIVATORS | 2007 |
|
RU2457207C2 |
OXOAZEPANYLACETAMIDE AND OXOAZEPANYLPHENOXYACETAMIDE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND METHOD FOR INHIBITING HEPATITIS TYPE C VIRUS (HCV) REPLICATION | 2006 |
|
RU2415132C2 |
PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING AND USING | 2006 |
|
RU2303597C1 |
N-ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITOR | 2003 |
|
RU2307831C9 |
NOVEL COMPOUNDS AND USE THEREOF IN THERAPY | 2004 |
|
RU2412190C2 |
Authors
Dates
2008-05-20—Published
2002-08-23—Filed